Gallus BioPharmaceuticals delivers end-to-end biologics process development and cGMP drug manufacturing for pre-clinical, clinical and commercial stages, including liquid fill-finish for pharmaceutical, biotechnology and government organizations.
Gallus is a uniquely flexible CMO, in empowering you, our clients – by accelerating your time to market through a transparent collaborative approach and through offering virtual ownership models driven by advanced single-use technologies. Our sweeping approval from every major regulatory body across the globe, including the FDA, EMA, HealthCanada, ANVISA and PMDA, ultimately makes us the ideal partner for your entire suite of contract manufacturing needs.